PROTEIN-BINDING OF DRUGS IN UREMIC AND NORMAL SERUM - ROLE OF ENDOGENOUS BINDING INHIBITORS

被引：216

作者：

SJOHOLM, I

KOBER, A

ODARCEDERLOF, I

BORGA, O

机构：

[1] KAROLINSKA HOSP,DEPT INTERN MED,S-10401 STOCKHOLM,SWEDEN

[2] HUDDINGE UNIV HOSP,DEPT CLIN PHARMACOL,S-14186 HUDDINGE,SWEDEN

[3] BIOMED CTR,DEPT PHARM BIOCHEM,S-75123 UPPSALA,SWEDEN

来源：

BIOCHEMICAL PHARMACOLOGY | 1976年 / 25卷 / 10期

关键词：

D O I：

10.1016/0006-2952(76)90370-1

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：1205 / 1213

页数：9

共 35 条

[1]

ANDERSSON L, 1969, INT J PROT RES, V1, P151

[2]

ANDREASEN F, 1974, ACTA PHARMACOL TOX, V34, P284

[3]

ANDREASEN F, 1974, ACTA PHARMACOL TOX, V35, P49

[4]

ANTON AH, 1971, ACTA PHARMACOL TOX, V29, P134

[5] BISALBUMINEMIA OF FAST TYPE WITH A HOMOZYGOTE [J].

BELL, HE ;

NICHOLSON, SF ;

THOMPSON, ZR .

CLINICA CHIMICA ACTA, 1967, 15 (02) :247-+

[6]

BLUM MR, 1972, NEW ENGL J MED, V286, P109

[7] ZUR PHARMAKOKINETIK VON SULFONAMIDEN UNTER PATHOLOGISCHEN BEDINGUNGEN [J].

BUTTNER, H ;

STAUDT, N ;

PORTWICH, F ;

MANZKE, E .

KLINISCHE WOCHENSCHRIFT, 1964, 42 (02) :103-&

[8]

CHEN RF, 1967, J BIOL CHEM, V242, P173

[9]

CHIGNELL CF, 1971, CLIN PHARMACOL THER, V12, P897

[10] TRIMETHOPRIM-SULFAMETHOXAZOLE - PHARMACODYNAMIC EFFECTS OF URINARY PH AND IMPAIRED RENAL FUNCTION - STUDIES IN HUMANS [J].

CRAIG, WA ;

KUNIN, CM .

ANNALS OF INTERNAL MEDICINE, 1973, 78 (04) :491-497

← 1 2 3 4 →